Digital Inverter Market to touch US$ 11 Billion by 2027 - FMI
Nov 28, 2017 12:01 pm UTC| Business
Valley Cottage, NY, Nov. 28, 2017 -- Future Market Insights has analysed various facets of the global market for digital inverters in a new research publication titled “Digital Inverter Market: Global Industry Analysis...
Nov 28, 2017 12:00 pm UTC| Business
Supports voice-over-BLE connectivity with Amazon AlexaReference Design employs Nordic’s nRF51822 SoC to wirelessly stream audio data to an Amazon Alexa smartphone application SUNNYVALE, Calif., Nov. 28, 2017 --...
Nov 28, 2017 12:00 pm UTC| Business
SAN DIEGO, Nov. 28, 2017 -- Global Payout, Inc. (OTCPink:GOHE) ("Global") is pleased to announce that its majority owned subsidiary, MoneyTrac Technology, Inc. ("MTRAC", the "Company") has established a key strategic...
Nov 28, 2017 12:00 pm UTC| Business
WALTHAM, Mass., Nov. 28, 2017 -- Deciphera Pharmaceuticals, Inc. (NASDAQ:DCPH) a clinical-stage biopharmaceutical company focused on addressing key mechanisms of tumor drug resistance, today announced that the European...
Axsome Therapeutics Announces AXS-07 for the Treatment of Migraine
Nov 28, 2017 12:00 pm UTC| Business
Incorporates new molecular entity for migraine and Axsome’s MoSEIC™ technology Potential for superior efficacy as compared to current treatments FDA Pre-IND meeting written guidance received Issued U.S. patent provides...
Silicon Valley Pioneer Adam Schwartz Joins New Frontier Data Board of Directors
Nov 28, 2017 12:00 pm UTC| Business
Washington, Nov. 28, 2017 -- New Frontier Data, the leading provider of data, analytics and business intelligence in the cannabis industry, is proud to announce the appointment of Adam Schwartz, Founder and CEO of...
G1 Therapeutics and AstraZeneca Enter Clinical Trial Collaboration in Non-Small Cell Lung Cancer
Nov 28, 2017 12:00 pm UTC| Business
RESEARCH TRIANGLE PARK, N.C., Nov. 28, 2017 -- G1 Therapeutics, Inc. (NASDAQ:GTHX), a clinical-stage oncology company, today announced a clinical trial collaboration with AstraZeneca to evaluate AstraZeneca’s epidermal...